These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15446556

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 3. [Relationships among the expression of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase and the prognosis of breast cancer].
    Yu ZG, Zhen JH, Jia HY, Zhang Q, Sun JZ.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 13; 86(22):1558-63. PubMed ID: 16854285
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
    Tokunaga Y, Takahashi K, Saito T.
    Hepatogastroenterology; 2005 Jun 13; 52(66):1715-21. PubMed ID: 16334763
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
    Miyoshi T, Kondo K, Toba H, Yoshida M, Fujino H, Kenzaki K, Sakiyama S, Takehisa M, Tangoku A.
    Anticancer Res; 2007 Jun 13; 27(4C):2641-8. PubMed ID: 17695427
    [Abstract] [Full Text] [Related]

  • 7. Importance of thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase expression at the invasive front of T3 rectal cancer as prognostic factors.
    Hayashi T, Kawahara H, Kobayashi S, Kashiwagi H, Hirai K, Yanaga K.
    Hepatogastroenterology; 2008 Jun 13; 55(82-83):403-6. PubMed ID: 18613375
    [Abstract] [Full Text] [Related]

  • 8. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A.
    Anticancer Res; 2007 Jun 13; 27(2):851-6. PubMed ID: 17465211
    [Abstract] [Full Text] [Related]

  • 9. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C, Aust DE, Meyer W, Baretton GB, Schwabe W, Häusler P, Becker H, Liersch T.
    J Pathol; 2004 Dec 13; 204(5):562-8. PubMed ID: 15538739
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.
    Okumura K, Mekata E, Shiomi H, Naitoh H, Abe H, Endo Y, Kurumi Y, Tani T.
    Cancer Chemother Pharmacol; 2008 Apr 13; 61(4):587-94. PubMed ID: 17520254
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H, Iinuma H, Watanabe T.
    Oncol Rep; 2008 Mar 13; 19(3):729-35. PubMed ID: 18288408
    [Abstract] [Full Text] [Related]

  • 14. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer.
    Hotta T, Kobayashi Y, Taniguchi K, Johata K, Sahara M, Watanabe T, Ochiai M, Tanimura H, Tsubota YT.
    Oncol Rep; 2004 Aug 13; 12(2):347-51. PubMed ID: 15254700
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J, Adleff V, Hitre E, Pap E, Réti A, Komlósi V, Budai B.
    Magy Onkol; 2007 Aug 13; 51(2):113-25. PubMed ID: 17660867
    [Abstract] [Full Text] [Related]

  • 16. Comparative analysis of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in colorectal cancer and surrounding normal tissue.
    Zimovjanova M, Sykora V, Novotny J, Gatek J, Petruzelka L, Holubec L, Pecen L.
    Neoplasma; 2005 Aug 13; 52(3):208-10. PubMed ID: 15875081
    [Abstract] [Full Text] [Related]

  • 17. Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
    Toi M, Ikeda T, Akiyama F, Kurosumi M, Tsuda H, Sakamoto G, Abe O.
    Int J Oncol; 2007 Oct 13; 31(4):899-906. PubMed ID: 17786323
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
    Jensen SA, Vainer B, Witton CJ, Jørgensen JT, Sørensen JB.
    Acta Oncol; 2008 Oct 13; 47(6):1054-61. PubMed ID: 18607850
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers.
    Hotta T, Taniguchi K, Kobayashi Y, Johata K, Sahara M, Naka T, Watanabe T, Ochiai M, Tanimura H, Tsubota YT.
    Oncol Rep; 2004 May 13; 11(5):1045-51. PubMed ID: 15069545
    [Abstract] [Full Text] [Related]

  • 20. Thymidylate synthase and dihydropyrimidine dehydrogenase expressions in gallbladder cancer.
    Ajiki T, Hirata K, Okazaki T, Horiuchi H, Fujita T, Habara K, Kamigaki T, Suzuki Y, Kuroda Y.
    Anticancer Res; 2006 May 13; 26(2B):1391-6. PubMed ID: 16619549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.